YY1 Induced FOXD2 ‐ AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2 / CDKN1A Axis
Oral Diseases · 2025
DOI: 10.1111/odi.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Zhonglin Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai…. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, RNA, Long Noncoding, Mouth Neoplasms, YY1 Transcription Factor. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovative Research Team of High-level Local Universities in Shanghai, Innovative Research Team of High-level Local University in Shanghai.
Abstract (Originalsprache)
Introduction
Long non‐coding RNAs ( lncRNAs ) have gained recognition as pivotal regulators in cancer biology. Among them, FOXD2 ‐ AS1 has been implicated in multiple cancer types; however, its functional significance and regulatory mechanisms in oral squamous cell carcinoma ( OSCC ) remain unclear. This study explores the mechanism of FOXD2 ‐ AS1 in OSCC progression, focusing on its interaction with the EZH2 / CDKN1A axis. Materials and Methods FOXD2 ‐ AS1 expression was analyzed in TCGA datasets and clinical OSCC samples, validated by qRT ‐ PCR / FISH . Functional impacts on proliferation, cell cycle (flow cytometry) and apoptosis were assessed. Mechanistic studies employed ChIP / RIP /dual‐luciferase assays for FOXD2 ‐ AS1 / YY1 / EZH2 interactions, with xenograft models evaluating tumorigenicity.
Results
FOXD2 ‐ AS1 was markedly upregulated in OSCC tissues and linked to poor prognosis. Its knockdown suppressed proliferation, induced G1 arrest, and promoted apoptosis, while overexpression reversed these effects. Mechanistically, YY1 transcriptionally activated FOXD2 ‐ AS1 , which bound EZH2 to enhance H3K27me3 deposition, repressing CDKN1A expression.
Discussion
Our findings revealed that the YY1 / FOXD2 ‐ AS1 / EZH2 axis drives OSCC progression by epigenetically silencing CDKN1A . FOXD2 ‐ AS1 demonstrates potential as both a prognostic biomarker and therapeutic target, highlighting the need for further exploration of lncRNA ‐based therapeutic approaches in OSCC .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai, China.
- Shanghai Key Laboratory of Stomatology, Shanghai, China.
- Xuchang Central Hospital, Xuchang, China.
- Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China.
ORCID-Profile: Zhonglin Yu, Xiaohu Lin, Wei Cao
Förderung
- National Natural Science Foundation of China
- Innovative Research Team of High-level Local Universities in Shanghai
- Innovative Research Team of High-level Local University in Shanghai
Zitieren
APA
Yu, Z., Lin, X., Zhao, P., Zhao, Z., Zeng, Y., Li, W., Zhou, W., Liu, L., & Cao, W. (2025). YY1 Induced FOXD2 ‐ AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2 / CDKN1A Axis. Oral Diseases. https://doi.org/10.1111/odi.70147
Vancouver
Yu Z, Lin X, Zhao P, Zhao Z, Zeng Y, Li W, et al. YY1 Induced FOXD2 ‐ AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2 / CDKN1A Axis. Oral Diseases. 2025. doi:10.1111/odi.70147
BibTeX
@article{Yu2025,
author = {Yu, Zhonglin and Lin, Xiaohu and Zhao, Pengfei and Zhao, Zhang and Zeng, Yao and Li, Wei and Zhou, Wenkai and Liu, Liu and Cao, Wei},
title = {YY1 Induced FOXD2 ‐ AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2 / CDKN1A Axis},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.70147}
}
EUVIMED